Results 11 to 20 of about 245,709 (254)
Neuroendocrine neoplasms of the digestive system – current classification and terminology [PDF]
Nowotwory, 2021 The system of classification and terminology of neuroendocrine neoplasms (NENs), updated in 2017 by AJCC and in 2019 by WHO, is now recommended for general use.
Agata Bałdys-Waligórska, Andrzej Nowak
doaj +2 more sources
Discover OncologyAims Insulinoma-associated protein 1 (INSM1) is a recently added nuclear marker for neuroendocrine differentiation. However, INSM1 expression in gastric neuroendocrine and non-neuroendocrine neoplasms has not been thoroughly investigated.
Sujeong Kim +3 more
doaj +2 more sources
Neuroendocrine neoplasms of the thymus [PDF]
Frontiers in ImmunologyNeuroendocrine neoplasms of the thymus (tNENs), including typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma, and small cell carcinoma, are rare tumors with scarce clinical and pathological data available in the literature.
Paul D. Barone, Chen Zhang
doaj +2 more sources
Spectrum of neuroendocrine neoplasms of GIT – a histomorphological study in a tertiary care centre
Journal of Medical Science, 2023 Background. Neuroendocrine neoplasms are diverse in terms of sites of origin, functional status, and degrees of aggressiveness. Since neuroendocrine cells are ubiquitous in the human body, these neoplasms can arise in different organs, with ...
Aparna Muralidhar, Pushpa Mahadevan
doaj +1 more source
, 2022 Pancreatic neuroendocrine neoplasms (PanNENs) are tumors with neuroendocrine differentiation and are divided into functioning (syndromic) or non-functioning based on the clinical syndromes. Insulinomas are the most common functioning NETs.
Maria Gaia Mastrosimini +9 more
core +1 more source
PLoS ONE, 2023 Hepatobiliary neuroendocrine neoplasms are rare cancers in humans and dogs. To date, no large-scale primary hepatobiliary neoplasm omics analyses exist in any species.
Tifini L Batts +9 more
doaj +1 more source
Medical treatment of neuroendocrine neoplasms [PDF]
, 2021 Medical therapy of clinically nonfunctioning (nonsecreting) low grade (grade 1–2) neuroendocrine neoplasms consists of first-line first generation somatostatin analogs and second-line or third-line peptide receptor radiotherapy with radiolabeled beta ...
de Herder, Wouter W. +2 more
core +1 more source
Challenges in high-grade neuroendocrine neoplasms and mixed neuroendocrine/non-neuroendocrine neoplasms [PDF]
, 2021 The growth in knowledge of the pathogenesis, molecular background, and immunohistochemical profile of neuroendocrine neoplasms (NENs) has led not only to an increased awareness of these diseases but also to several changes of the nomenclature.
La Rosa S, La Rosa, S., Stefano La Rosa
core +1 more source
Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.
, 2020 The nomenclature and classification of pancreatic neuroendocrine neoplasms has evolved in the last 15 years based on the advances in knowledge of the genomics, clinical behaviour and response to therapies.
Lam, Alfred King-Yin, Ishida, Hirotaka
core +1 more source
Diagnosis and therapy of neuroendocrine neoplasms of the gastrointestinal tract [PDF]
, 2016 A neuroendocrine neoplasm (NEN) is a tumor that originates in neuroendocrine cells capable of producing peptides or amines. Neuroendocrine neoplasms of the digestive system are also referred to as gastroenteropancreatic neuroendocrine neoplasms (GEP NEN)
Aleksandra Izabela Czerw +3 more
core +2 more sources